Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Biomaterials ; 292: 121940, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36493714

RESUMO

Intraperitoneal adhesions (IAs) are a major complication arising from abdominal repair surgeries, including hernia repair procedures. Herein, we fabricated a composite mesh device using a macroporous monofilament polypropylene mesh and a degradable elastomer coating designed to meet the requirements of this clinical application. The degradable elastomer was synthesized using an organo-base catalyzed thiol-yne addition polymerization that affords independent control of degradation rate and mechanical properties. The elastomeric coating was further enhanced by the covalent tethering of antifouling zwitterion molecules. Mechanical testing demonstrated the elastomer forms a robust coating on the polypropylene mesh does not exhibit micro-fractures, cracks or mechanical delamination under cyclic fatigue testing that exceeds peak abdominal loads (50 N/cm). Quartz crystal microbalance measurements showed the zwitterionic functionalized elastomer further reduced fibrinogen adsorption by 73% in vitro when compared to unfunctionalized elastomer controls. The elastomer exhibited degradation with limited tissue response in a 10-week murine subcutaneous implantation model. We also evaluated the composite mesh in an 84-day study in a rabbit cecal abrasion hernia adhesion model. The zwitterionic composite mesh significantly reduced the extent and tenacity of IAs by 94% and 90% respectively with respect to uncoated polypropylene mesh. The resulting composite mesh device is an excellent candidate to reduce complications related to abdominal repair through suppressed fouling and adhesion formation, reduced tissue inflammation, and appropriate degradation rate.


Assuntos
Polipropilenos , Telas Cirúrgicas , Coelhos , Camundongos , Animais , Telas Cirúrgicas/efeitos adversos , Adesivos , Elastômeros , Implantes Absorvíveis , Aderências Teciduais/prevenção & controle , Aderências Teciduais/etiologia , Hérnia/prevenção & controle
2.
Nat Commun ; 12(1): 1367, 2021 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-33649338

RESUMO

Effective control of pain management has the potential to significantly decrease the need for prescription opioids following a surgical procedure. While extended release products for pain management are available commercially, the implementation of a device that safely and reliably provides extended analgesia and is sufficiently flexible to facilitate a diverse array of release profiles would serve to advance patient comfort, quality of care and compliance following surgical procedures. Herein, we review current polymeric systems that could be utilized in new, controlled post-operative pain management devices and highlight where opportunities for improvement exist.


Assuntos
Sistemas de Liberação de Medicamentos , Manejo da Dor , Dor Pós-Operatória/tratamento farmacológico , Polímeros/química , Analgésicos/administração & dosagem , Analgésicos/uso terapêutico , Animais , Humanos , Controle Social Formal
3.
J Control Release ; 329: 316-327, 2021 01 10.
Artigo em Inglês | MEDLINE | ID: mdl-33278481

RESUMO

Medical prescriptions for the alleviation of post-surgical pain are the most abundant source of opioids in circulation. As a systemic drug delivery source, opioids leave patients at high risk for side effects after being dosed. Given the significant rate of unauthorized use, distribution, addiction, and opioid related deaths, an alternative method of post-surgical analgesia is needed. Herein, we report the use of bio-resorbable poly(ester urea) (PEU) films that controllably deliver a non-opioid COX-2 inhibitor, etoricoxib, in vivo and in vitro as a model system for post-surgical pain control. PEU composition, drug-load, and film thickness were varied to selectively control etoricoxib elution. Elution data were fit to a Higuchi model, and the diffusion constant of etoricoxib was calculated in each of the films. Pharmacokinetic (pK) data from an in vivo rat model showed the local tissue concentration of etoricoxib at the study endpoint to be up to 23-fold higher in tissue then plasma. In a well-established mouse model of diabetic neuropathic pain in vivo film implantation showed effective relief of pain for more than 4 days post-implantation and efficacious local etoricoxib delivery. Overall, implementation of local drug delivery systems such as this could reduce the need for opioid prescriptions associated with current pain management strategies.


Assuntos
Ésteres , Ureia , Animais , Inibidores de Ciclo-Oxigenase 2/uso terapêutico , Preparações de Ação Retardada/uso terapêutico , Método Duplo-Cego , Ésteres/uso terapêutico , Etoricoxib/uso terapêutico , Humanos , Camundongos , Dor Pós-Operatória/tratamento farmacológico , Piridinas/uso terapêutico , Ratos , Sulfonas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA